— Know what they know.
Not Investment Advice
Also trades as: COLO-B.CO (CPH) · $vol 22M · CBHD.DE (XETRA) · $vol 0M · CLPBF (OTC) · $vol 0M

CLPBY OTC

Coloplast A/S
1W: -4.3% 1M: -16.5% 3M: +1.3% YTD: -26.2% 1Y: -28.4% 3Y: -36.9% 5Y: -59.0%
$6.18
-0.08 (-1.28%)
 
Weekly Expected Move ±2.6%
$6 $6 $6 $6 $7
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 32 · $13.9B mcap · 143M float · 0.239% daily turnover · Short 34% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$13.9B
52W Range5.64-9.7
Volume72,524
Avg Volume342,171
Beta0.53
Dividend$0.36
Analyst Ratings
3 Buy 3 Hold 2 Sell
Consensus Buy
Company Info
CEOGavin Wood
Employees16,907
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2014-01-13
Holtedam 1
Humlebæk, ZE 3050
DK
45 49 11 11 11
About Coloplast A/S

Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services. Its extensive reach spans Denmark, the United States, the United Kingdom, France, and numerous other international regions. The company's activities are organized into three primary segments: Chronic Care, Interventional Urology, and Wound & Skin Care. Within Chronic Care, Coloplast provides advanced ostomy solutions, including the SenSura Mio, recognized for its adaptable fit and discretion, alongside other SenSura offerings and Brava brand accessories. This segment also delivers continence care products such as Conveen Active urine bags, SpeediCath catheters for diverse users, and the Peristeen transanal irrigation system. The Wound & Skin Care division features innovative dressings like the conforming Biatain Silicone and the hydrocolloid Comfeel. Additionally, it offers a broad spectrum of skin care items, encompassing bathing and cleansing products, moisturizers, skin protectants, antifungal treatments, hand cleansers, odor control solutions, and the specialized InterDry system for managing skin folds. Finally, the Interventional Urology segment is dedicated to crafting and commercializing surgical devices that address a range of urological and gynecological conditions, such as urinary stone disease, benign prostatic hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms